A Prospective Randomized Controlled Trial comparing the Efficacy of Dexamethasone versus Triamcinolone Acetonide Injection for the Treatment of Primary Trigger

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20230222010

Enrollment

100

Registered

2023-02-22

Start date

2020-04-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Trigger Finger trigger finger stenosing tenosynovitis steroid injection

Interventions

Dexamethasone injection,Triamcinolone injection

Active Comparator Drug,Active Comparator Drug

Dexamethasone,Triamcinolone

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Primary Trigger Finger Grade I II IIIA IIIB No prior treatment

Exclusion criteria

Exclusion criteria: Inflammatory joint disease Prior trauma Uncontrolled DM Allergic to steroid or local anesthetic drug

Design outcomes

Primary

Measure	Time frame
Resolution of symptoms 4 weeks Percent	—

Secondary

Measure	Time frame
Pain score 4 weeks Numerical rating scale	—

Countries

Thailand

Contacts

Public ContactVarachaya Khwanjaipanich

Chonburi Hospital

viiviiewz.view@gmail.com0805662611

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026